IPO - Profile

Summary

We partner with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets, and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse functions.

We call our process biofacturing, and it creates better products faster, cheaper and more More

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$31.00 16,300,000 Positive High 32.66%

Offering Team

  • Legal counsel
  • Wilson Sonsini Goodrich & Rosati, P.C
  • Auditors
  • Ernst & Young LLP

Deal Highlights

Deal Tracker

IPO Dates

Filing 21 Apr, 2021

Offer 22 Apr, 2021

Look Ahead

Lock Up Expiry Oct 22, 2021

IPO Terms

Offer Price $31.00
Offer Size 16M

Market Sentiments

Stock Price